NL8403856A - 5-pyrimidinecarboxamiden en thiocarboxamiden en behandeling van leukemie en tumoren daarmee. - Google Patents

5-pyrimidinecarboxamiden en thiocarboxamiden en behandeling van leukemie en tumoren daarmee. Download PDF

Info

Publication number
NL8403856A
NL8403856A NL8403856A NL8403856A NL8403856A NL 8403856 A NL8403856 A NL 8403856A NL 8403856 A NL8403856 A NL 8403856A NL 8403856 A NL8403856 A NL 8403856A NL 8403856 A NL8403856 A NL 8403856A
Authority
NL
Netherlands
Prior art keywords
pyrimidine carboxamide
hydroxy
pyrimidine
thioxo
oxo
Prior art date
Application number
NL8403856A
Other languages
English (en)
Dutch (nl)
Original Assignee
Uniroyal Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Uniroyal Inc filed Critical Uniroyal Inc
Publication of NL8403856A publication Critical patent/NL8403856A/nl

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52—Two oxygen atoms
    • C07D239/54—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557—Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A61P35/02—Antineoplastic agents specific for leukemia
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D239/00—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28—Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46—Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/60—Three or more oxygen or sulfur atoms
    • C07D239/66—Thiobarbituric acids

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Oncology (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
NL8403856A 1983-12-19 1984-12-19 5-pyrimidinecarboxamiden en thiocarboxamiden en behandeling van leukemie en tumoren daarmee. NL8403856A (nl)

Applications Claiming Priority (6)

Application Number Priority Date Filing Date Title
US56269383A 1983-12-19 1983-12-19
US56269383 1983-12-19
US66520184A 1984-10-26 1984-10-26
US66526784A 1984-10-26 1984-10-26
US66526784 1984-10-26
US66520184 1984-10-26

Publications (1)

Publication Number Publication Date
NL8403856A true NL8403856A (nl) 1985-07-16

Family

ID=27415896

Family Applications (1)

Application Number Title Priority Date Filing Date
NL8403856A NL8403856A (nl) 1983-12-19 1984-12-19 5-pyrimidinecarboxamiden en thiocarboxamiden en behandeling van leukemie en tumoren daarmee.

Country Status (19)

Country Link
US (1) US4634707A (da)
JP (1) JPH0660164B2 (da)
AT (1) AT394194B (da)
AU (1) AU580746B2 (da)
BE (1) BE901301A (da)
CH (1) CH671225A5 (da)
DE (1) DE3446371A1 (da)
DK (1) DK164055C (da)
ES (1) ES8606296A1 (da)
FR (1) FR2557108B1 (da)
GB (1) GB2152047B (da)
GR (1) GR82494B (da)
IE (1) IE57675B1 (da)
IL (1) IL73840A (da)
IT (1) IT1213257B (da)
LU (1) LU85696A1 (da)
NL (1) NL8403856A (da)
NZ (2) NZ220399A (da)
SE (1) SE469171B (da)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB2145087B (en) * 1983-08-19 1987-02-04 Ciba Geigy Ag Barbituric acid derivatives
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
PH24423A (en) * 1985-02-15 1990-06-25 Ciba Geigy Ag 5-(azolyloxyphenylcarbamoyl)barbituric acid derivatives as anthelmintics
US4636508A (en) * 1985-04-22 1987-01-13 Uniroyal Chemical Company, Inc. 5-pyrimidinecarboxyamides and treatment of leukemia therewith
US4845217A (en) * 1985-05-17 1989-07-04 Uniroyal Chemical Ltd./Ltee Purification of 5-pyrimidinecarboxamides
EP0202823A3 (en) * 1985-05-17 1987-11-19 Uniroyal Limited Purification of 5-pyrimidinecarboxamides
US4880811A (en) * 1987-06-24 1989-11-14 Memorial Hospital For Cancer And Allied Diseases Use of C-5 mono-substituted barbiturates to treat disorders of uric acid metabolism
US4920126A (en) * 1988-05-10 1990-04-24 Uniroyal Chemical Ltd/Uniroyal Chemical Ltee Barbituric acid derivative and treatment of leukemia and tumors therewith
AU7540991A (en) * 1990-03-09 1991-10-10 Memorial Hospital For Cancer And Allied Diseases C-5 mono-substituted barbiturates in combination with therapeutic agents and uses thereof
CA2404898A1 (en) 2000-04-24 2001-11-01 Aryx Therapeutics Ultrashort acting hypnotic barbiturates
WO2015123003A1 (en) * 2014-02-14 2015-08-20 Warrell Raymond P Bifunctional compounds and use for reducing uric acid levels
KR20170103803A (ko) * 2015-01-22 2017-09-13 주니어 워렐 레이먼드 피. 요산 수준의 저감을 위한 이작용성 화합물 및 용도
TWI771303B (zh) 2016-06-30 2022-07-21 美商艾克奎斯特有限責任公司 化合物及其於降低尿酸位準之用途(一)
BR112019000201A2 (pt) 2016-07-06 2019-07-09 Acquist Llc compostos e seu uso na redução dos níveis de ácido úrico
IT201700028709A1 (it) 2017-03-15 2018-09-15 Fondazione St Italiano Tecnologia Acidi-5-carbossamide-2-tiobarbiturici e loro uso come medicamenti

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH602664A5 (en) * 1973-06-14 1978-07-31 Sandoz Ag 2-Tert. amino-alkylamino-pyrimidine derivs.
DE2405733C2 (de) * 1974-02-07 1984-12-13 Bayer Ag, 5090 Leverkusen Amidocarbonylthiobarbitursäurederivate und deren Salze, Verfahren zu ihrer Herstellung sowie ihre Verwendung zur Bekämpfung von Insekten, Milben und Pilzen
DE2405732A1 (de) * 1974-02-07 1975-08-21 Bayer Ag Ekto- und endoparasitenmittel
CH614944A5 (en) * 1974-04-16 1979-12-28 Sandoz Ag Process for the preparation of novel pyrimidine derivatives
PL103086B1 (pl) * 1976-05-06 1979-05-31 Ciba Geigy Ag Srodek owadobojczy
CH616563A5 (en) * 1976-05-06 1980-04-15 Ciba Geigy Ag Pesticide containing a 5-phenylcarbamoylbarbituric acid as active ingredient
DE2624856A1 (de) * 1976-06-03 1977-12-22 Hoechst Ag 2-thiohexahydropyrimidin-4,6-dion-derivate und verfahren zu ihrer herstellung
US4283444A (en) * 1978-09-12 1981-08-11 Ciba-Geigy Corporation Method of protecting keratinous material from attack by insects that feed on keratin by treatment with 5-phenylcarbamoylbarbituric acid compounds
EP0010941B1 (en) * 1978-10-30 1982-05-12 Fujisawa Pharmaceutical Co., Ltd. 5-fluorouracil derivatives, preparation thereof and their pharmaceutical compositions
US4349552A (en) * 1978-10-30 1982-09-14 Fujisawa Pharmaceutical Company, Ltd. 5-Fluorouracil derivatives, and their pharmaceutical compositions
CH654720A5 (de) * 1981-09-03 1986-03-14 Ciba Geigy Ag Lagerstabile mottenschutzformulierungen.
US4410524A (en) * 1982-06-01 1983-10-18 American Cyanamid Company Novel 1,4-bis(substituted-amino)-5,8-dihydroxyanthraquinones and leuco bases thereof
CH658770A5 (de) * 1982-08-26 1986-12-15 Ciba Geigy Ag Motten- und kaeferschutzmittel.
EP0102327A3 (de) * 1982-08-26 1985-05-15 Ciba-Geigy Ag Barbitursäurederivate als Anthelmintika
GB8431832D0 (en) * 1983-12-19 1985-01-30 Uniroyal Inc 5-pyrimidinecarboxamides
EP0167491A3 (de) * 1984-07-06 1986-12-30 Ciba-Geigy Ag Thiobarbitursäurederivate
JPS641445A (en) 1987-06-22 1989-01-05 Toshiba Corp Manufacture of stator coil

Also Published As

Publication number Publication date
DK164055C (da) 1992-09-28
NZ220399A (en) 1987-09-30
SE8406450D0 (sv) 1984-12-18
IE57675B1 (en) 1993-02-24
DK609184A (da) 1985-06-20
IL73840A (en) 1988-11-15
SE8406450L (sv) 1985-06-20
IL73840A0 (en) 1985-03-31
GB2152047A (en) 1985-07-31
CH671225A5 (da) 1989-08-15
FR2557108B1 (fr) 1988-11-18
AU580746B2 (en) 1989-02-02
DE3446371C2 (da) 1990-08-16
BE901301A (fr) 1985-06-18
IT1213257B (it) 1989-12-14
DK164055B (da) 1992-05-04
IT8424104A0 (it) 1984-12-18
GB2152047B (en) 1988-04-27
GR82494B (en) 1985-04-19
AU3690884A (en) 1985-07-04
LU85696A1 (fr) 1985-09-12
IE843237L (en) 1985-06-19
FR2557108A1 (fr) 1985-06-28
SE469171B (sv) 1993-05-24
AT394194B (de) 1992-02-10
US4634707A (en) 1987-01-06
JPH0660164B2 (ja) 1994-08-10
ATA402684A (de) 1991-08-15
JPS62174058A (ja) 1987-07-30
GB8432112D0 (en) 1985-01-30
DK609184D0 (da) 1984-12-18
NZ210599A (en) 1987-09-30
DE3446371A1 (de) 1985-06-27
ES8606296A1 (es) 1986-04-16
ES538829A0 (es) 1986-04-16

Similar Documents

Publication Publication Date Title
NL8403856A (nl) 5-pyrimidinecarboxamiden en thiocarboxamiden en behandeling van leukemie en tumoren daarmee.
DE69426423T2 (de) NEUE HEMMER VON URIDINPHOSPHORYLASE (UrdPase) UND DIHYDROURACILDEHYDROGENASE (DHUDase)
PL136637B1 (en) Process for preparing novel 9-/1,3-dihydroxy-2-porpoxymethyl/-guanine
PL192864B1 (pl) Pochodna pirazyny i środek farmaceutyczny
PL117396B1 (en) Process for preparing novel derivatives of benzimidazole
JPH0460987B2 (da)
CH637385A5 (de) Verfahren zur herstellung von pyrimidin-derivaten und von deren pharmakologisch vertraeglichen salzen.
US4636508A (en) 5-pyrimidinecarboxyamides and treatment of leukemia therewith
PL128791B1 (en) Process for manufacturing novel substituted bis-hydrazones-9,10-anthracene
US4544759A (en) Platinum complexes of antitumor agents
US4103009A (en) Benzoguanamine derivatives
EP0000334B1 (de) 2,4--Diamino-5-benzylpyrimidine, Verfahren zu ihrer Herstellung und diese enthaltende Arzneimittel
US4128643A (en) 4-Quinazolinyl-guanidines
CH642668A5 (de) 2,6-diaminonebularine, verfahren zu deren herstellung und sie enthaltende pharmazeutische praeparate.
HUT67899A (en) Thioxanthenone antitumor agents
PL128998B1 (en) Process for preparing novel 2-amino-3-benzoylphenylacetamides and their derivatives
US4224327A (en) 4-Pyrimidyl sulfides for the treatment of gastric ulcers
US4478839A (en) Substituted pyrimid-2-ones, the salts thereof, processes for their preparation and pharmaceutical compositions containing them
JPH0441145B2 (da)
US3485834A (en) Hypoglycemic sulfonamido-s-triazines
CA1256861A (en) 5-pyrimidinecarboxamides and treatment of leukemia and tumors therewith
US3275512A (en) Process for treating inflammation with biphenylcarbamates
EP0012725B1 (de) Chinoxalin-Di-N-oxid-Derivate, Verfahren zu ihrer Herstellung, Mittel diese enthaltend und ihre Verwendung
EP0210291A1 (en) Platinum complexes of antitumor agents
DE2439283A1 (de) Neue pyrimidinderivate und verfahren zu deren herstellung

Legal Events

Date Code Title Description
CNR Transfer of rights (patent application after its laying open for public inspection)

Free format text: UNIROYAL CHEMICAL COMPANY, INC. TE MIDDLEBURY, CONNECTICUT, VER. ST. V. AM. EN UNIROYAL LTD. TE DONMILLS, CANADA.

BA A request for search or an international-type search has been filed
BB A search report has been drawn up
BC A request for examination has been filed
DNT Communications of changes of names of applicants whose applications have been laid open to public inspection

Free format text: UNIROYAL CHEMICAL COMPANY, INC. EN UNIROYAL CHEMICAL

BV The patent application has lapsed